Sleigh, Kenna M, Marra, Fawziah H, Stiver, H Grant · American journal of respiratory medicine : drugs, devices, and other interventions · 2002 · DOI
This study looked at whether people with ME/CFS should get the flu vaccine, since many patients worry it might worsen their symptoms or harm their already-altered immune system. Researchers reviewed patient concerns and clinical trial data and found that flu vaccination actually produces protective antibodies in ME/CFS patients without making their symptoms worse, though some patients reported more side effects after the shot (which turned out to overlap with ME/CFS symptoms they already had).
This study directly addresses a major barrier to preventive healthcare in ME/CFS: patient fear that vaccination will worsen their condition. By providing evidence from a controlled trial that flu vaccination produces adequate immune protection without symptom deterioration, it supports informed decision-making and helps clinicians counsel patients on disease prevention strategies.
This study does not prove that vaccination is universally safe or beneficial for all ME/CFS patients, as individual responses vary considerably. It also does not establish whether perceived adverse effects in some patients represent true vaccine reactions versus symptom overlap, and does not address other types of vaccines beyond influenza. The small sample size in the clinical trial limits generalizability.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →